NPI registry status
Active
2026 NPPES data Ph.D. Medical Genetics NPI 1720013089 M.D.
Verify on CMS → Jeffrey Moore, M.D.
Ph.D. Medical Genetics in Nashville, Tennessee.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 354 in Ph.D. Medical Genetics, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
299
Medicare Part D claims · 19 beneficiaries · Ph.D. Medical Genetics avg: 1K
Industry payments
$16.94
1 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Jeffrey Moore, M.D. filed 299 Medicare Part D claims in 2024 as a Ph.D. Medical Genetics in Nashville, Tennessee.
- 299
- Part D claims, 2024
- $16.94
- industry payments (Sunshine Act)
- ≥48th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Jeffrey Moore, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1720013089), first enumerated 07/12/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 299 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Industry payment transparency
$16.94 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1720013089 · Ph.D. Medical Genetics
NPI-10 · ENUM-LEGACY · TAX-TRACE · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1720013089
- ENUM-LEGACY 2006
- TAX-TRACE 354
- RX-LIGHT 299
- BOOK-THIN 13 in Tennessee
- PHOTO-ENUM Michael Paszek, MD · 2006
Jeffrey Moore, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
299 ≥ 48th percentile 48% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
What does the federal data show about Jeffrey Moore, M.D.?
Quality data not reportedPrimary specialty
Ph.D. Medical Genetics
Medicare Part D claims
299 71% vs specialty avg
Specialty distribution in Tennessee
How Ph.D. Medical Genetics compares to other specialties among Tennessee providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Ph.D. Medical Genetics. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1720013089 |
|---|---|
| Specialty | Ph.D. Medical Genetics |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 07/12/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Jeffrey Moore, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$17
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
299
Total Claims
$31K
Total Drug Cost
19
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 554.2
- Total Day Supply
- 15,872
- Generic Drug Cost
- $3K
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 66.8 years
- Avg HCC Risk Score
- 1.25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Jeffrey Moore, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Carvedilol
Carvedilol
20 claims
- Amlodipine Besylate
Amlodipine Besylate
15 claims
- Prednisone
Prednisone
14 claims
- Losartan Potassium
Losartan Potassium
13 claims
- Metformin Hcl
Metformin Hcl
13 claims
- Atorvastatin Calcium
Atorvastatin Calcium
11 claims
| Drug | Claims |
|---|---|
| Carvedilol | 20 |
| Amlodipine Besylate | 15 |
| Prednisone | 14 |
| Losartan Potassium | 13 |
| Metformin Hcl | 13 |
| Atorvastatin Calcium | 11 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ph.D. Medical Genetics Overview
How Jeffrey Moore, M.D. fits within the Ph.D. Medical Genetics landscape nationally.
354
Ph.D. Medical Genetics Providers in US
46
States with Ph.D. Medical Genetics
1,029
Avg Claims per Provider
Jeffrey Moore, M.D.'s 299 claims are below the specialty average of 1,029.
Nationwide Ph.D. Medical Genetics peers with similar MIPS or enrollment year
Two federal-record peer sets for Moore, both outside Tennessee so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ph.D. Medical Genetics Providers in Tennessee
Other clinicians with the same primary specialty enrolled in Tennessee, drawn from the same CMS NPPES roster as Moore.
One of 13 Ph.D. Medical Genetics providers enrolled in Tennessee, 5 are shown here.
Dr. Ilse Anderson
MD
Knoxville, TN
Dr. Marcia Bowden
MD
Memphis, TN
Dr. Floyd Burton
M.D.
Kingsport, TN
Christopher Chrisohon
PA-C
Elizabethton, TN
Dr. David Fenner
MD
Elizabethton, TN
Compare Ph.D. Medical Genetics nationally: see state-by-state distribution →
Frequently Asked Questions
What is Jeffrey Moore, M.D.'s specialty? ▼
Jeffrey Moore, M.D. specializes in Ph.D. Medical Genetics and practices in Nashville, Tennessee. Credentials: M.D..
How much does Jeffrey Moore, M.D. prescribe under Medicare Part D? ▼
In 2024, Jeffrey Moore, M.D. wrote 299 Medicare Part D claims totaling $31K in drug costs for 19 beneficiaries.
Where is Jeffrey Moore, M.D. located? ▼
Jeffrey Moore, M.D. is located at 514 FISK ST, Nashville, TN, 37203. Phone: (615) 321-0776.
What is Jeffrey Moore, M.D.'s NPI number? ▼
Jeffrey Moore, M.D.'s National Provider Identifier (NPI) is 1720013089, issued on 07/12/2006.
How many Ph.D. Medical Genetics providers are there in the US? ▼
There are 354 Ph.D. Medical Genetics providers across 46 states in the US. The average Ph.D. Medical Genetics provider writes 1,029 Medicare Part D claims per year.
What drugs does Jeffrey Moore, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Jeffrey Moore, M.D.'s most frequently prescribed drugs include Carvedilol, Amlodipine Besylate, Prednisone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Jeffrey Moore, M.D. accept Medicare? ▼
Jeffrey Moore, M.D. appears in CMS Medicare data with 299 Part D claims and 19 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Jeffrey Moore, M.D.'s credentials? ▼
Jeffrey Moore, M.D.'s NPI is 1720013089 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.